Related Experiment Video
Updated: Jun 21, 2026

Ultrastructural Expansion Microscopy in Three In Vitro Life Cycle Stages of Trypanosoma cruzi
Published on: May 12, 2023
The steady-state transcriptome of the four major life-cycle stages of Trypanosoma cruzi
Todd A Minning1, D Brent Weatherly, James Atwood
1Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia 30602, USA. tminning@uga.edu
Background:
Chronic chagasic cardiomyopathy is a debilitating and frequently fatal outcome of human infection with the protozoan parasite, Trypanosoma cruzi. Microarray analysis of gene expression during the T. cruzi life-cycle could be a valuable means of identifying drug and vaccine targets based on their appropriate expression patterns, but results from previous microarray studies in T. cruzi and related kinetoplastid parasites have suggested that the transcript abundances of most genes in these organisms do not vary significantly between life-cycle stages.
Results:
In this study, we used whole genome, oligonucleotide microarrays to globally determine the extent to which T. cruzi regulates mRNA relative abundances over the course of its complete life-cycle. In contrast to previous microarray studies in kinetoplastids, we observed that relative transcript abundances for over 50% of the genes detected on the T. cruzi microarrays were significantly regulated during the T. cruzi life-cycle. The significant regulation of 25 of these genes was confirmed by quantitative reverse-transcriptase PCR (qRT-PCR). The T. cruzi transcriptome also mirrored published protein expression data for several functional groups. Among the differentially regulated genes were members of paralog clusters, nearly 10% of which showed divergent expression patterns between cluster members.
Conclusion:
Taken together, these data support the conclusion that transcript abundance is an important level of gene expression regulation in T. cruzi. Thus, microarray analysis is a valuable screening tool for identifying stage-regulated T. cruzi genes and metabolic pathways.
Insights
Gene expression in Trypanosoma cruzi significantly varies across its life-cycle, contrary to previous beliefs. This finding highlights transcript abundance as a key regulatory mechanism and aids in identifying drug targets for Chagas disease.
Area of Science:
- Molecular Biology
- Parasitology
- Genomics
Background:
- Chronic chagasic cardiomyopathy, a severe outcome of Trypanosoma cruzi infection, necessitates novel therapeutic and preventative strategies.
- Previous studies suggested limited gene expression variability in T. cruzi life stages, hindering target identification.
Purpose of the Study:
- To comprehensively assess mRNA relative abundance regulation throughout the complete Trypanosoma cruzi life-cycle using whole-genome microarrays.
- To identify stage-regulated genes and metabolic pathways for potential drug and vaccine development.
Main Methods:
- Whole-genome oligonucleotide microarrays were employed to analyze global gene expression patterns.
- Quantitative reverse-transcriptase PCR (qRT-PCR) was used to validate the regulation of selected genes.
- Transcriptome data were compared with existing protein expression data.
Main Results:
- Over 50% of detected genes exhibited significant regulation in mRNA relative abundances during the T. cruzi life-cycle.
- Significant regulation was confirmed for 25 genes via qRT-PCR.
- Nearly 10% of gene paralog clusters displayed divergent expression patterns among members.
Conclusions:
- Transcript abundance represents a crucial level of gene expression regulation in Trypanosoma cruzi.
- Microarray analysis is an effective tool for discovering stage-regulated genes and metabolic pathways in T. cruzi, aiding in the search for therapeutic interventions.
Related Concept Videos
American Trypanosomiasis
Retrovirus Life Cycles
Master Transcription Regulators
Master Transcription Regulators
General Transcription Factors
Leishmaniasis

